BTAI - BIOXCEL THERAPEUTICS INC
This page shows which of the focused investors we track hold BTAI and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2025 it was held by 1 manager with an aggregate reported value of $617.44K, which is 0.00% of the combined portfolio.
As of Q3 2025, 1 tracked institutional manager held BTAI (BIOXCEL THERAPEUTICS INC) with an aggregate reported value of $617.44K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BTAI — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2025
- Ticker
- BTAI
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Howard Marks - Oaktree Capital Management | 0.01% | - | 241,188 | $617.44K |
Loading holder history for BTAI…